CCL21 Cancer Immunotherapy
Cancer, a major health problem, affects 12 million people worldwide every year. With surgery and chemo-radiation the long term survival rate for the majority of cancer patients is dismal. Thus novel treatments are urgently needed. Immunotherapy, the harnessing of the immune system to destroy cancer...
Main Authors: | Yuan Lin, Sherven Sharma, Maie St. John |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/6/2/1098 |
Similar Items
-
PD-1 Immune Checkpoint Blockade Promotes Therapeutic Cancer Vaccine to Eradicate Lung Cancer
by: Pournima Kadam, et al.
Published: (2020-06-01) -
Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine
by: Pournima Kadam, et al.
Published: (2020-11-01) -
Shape and Function of Interstitial Chemokine CCL21 Gradients Are Independent of Heparan Sulfates Produced by Lymphatic Endothelium
by: Kari Vaahtomeri, et al.
Published: (2021-02-01) -
Contribution of Heparan Sulphate Binding in CCL21-Mediated Migration of Breast Cancer Cells
by: Irene del Molino del Barrio, et al.
Published: (2021-07-01) -
The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression
by: Balsam Rizeq, et al.
Published: (2020-04-01)